Juliann E Cho1, Melissa C Helm2, Joseph H Helm2, Neil Mier2, Andrew S Kastenmeier2, Jon C Gould2, Matthew I Goldblatt3. 1. Department of Anesthesia, University of California Davis, Davis, CA, USA. 2. Division of General Surgery, Department of Surgery, Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI, 53226, USA. 3. Division of General Surgery, Department of Surgery, Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI, 53226, USA. mgoldbla@mcw.edu.
Abstract
BACKGROUND: There is little consensus on the ideal anatomical placement of bio-absorbable mesh. We hypothesized that retro-rectus placement of bio-absorbable mesh would significantly reduce recurrence rates when compared to intraperitoneal mesh placement. METHODS: A retrospective review was conducted of patients who underwent open complex ventral hernia repair using bio-absorbable mesh (Bio-A, Gore, Flagstaff, AZ). Patient demographics and Centers for Disease Control wound type were collected. RESULTS: A total of 81 patients were included. Seventy-four (91.4%) of these hernia repairs had mesh in the retro-rectus position, while 7 (8.6%) had intraperitoneal mesh placement. Patient demographics, including preoperative comorbidities, did not differ between groups. The retro-rectus group trended to have larger hernia defects (156.2 cm2) compared to the intraperitoneal group (63.9 cm2) (p = 0.058). Overall complications (e.g., dehiscence, wound drainage, cellulitis, sepsis) were also similar in both groups of patients. Recurrence rates in the retro-rectus and intraperitoneal group were 8.1% and 42.9%, respectively (p = 0.005). When evaluating only patients with CDC class 1 wounds, the recurrence rate in the retro-rectus group was 8.2% and the intraperitoneal group was 50% (p = 0.02). Overall, the average patient follow-up was 22 months and did not differ between groups. Both the retro-rectus and intraperitoneal groups indicated a significant (p < 0.05) improvement in quality of life from baseline. No long-term (> 7 days) antibiotics were used and no mesh implants were removed during the study. CONCLUSION: Patients who underwent open complex ventral hernia repairs with bio-absorbable mesh in the retro-rectus position experienced lower overall complication rates than those with intraperitoneal mesh placement. Despite a larger hernia defect in the retro-rectus group, recurrence rates were significantly reduced with retro-rectus placement of mesh compared to intraperitoneal placement. In addition, recurrence rates using bio-absorbable mesh in clean wounds are comparable to previously published recurrence rates with permanent mesh.
BACKGROUND: There is little consensus on the ideal anatomical placement of bio-absorbable mesh. We hypothesized that retro-rectus placement of bio-absorbable mesh would significantly reduce recurrence rates when compared to intraperitoneal mesh placement. METHODS: A retrospective review was conducted of patients who underwent open complex ventral hernia repair using bio-absorbable mesh (Bio-A, Gore, Flagstaff, AZ). Patient demographics and Centers for Disease Control wound type were collected. RESULTS: A total of 81 patients were included. Seventy-four (91.4%) of these hernia repairs had mesh in the retro-rectus position, while 7 (8.6%) had intraperitoneal mesh placement. Patient demographics, including preoperative comorbidities, did not differ between groups. The retro-rectus group trended to have larger hernia defects (156.2 cm2) compared to the intraperitoneal group (63.9 cm2) (p = 0.058). Overall complications (e.g., dehiscence, wound drainage, cellulitis, sepsis) were also similar in both groups of patients. Recurrence rates in the retro-rectus and intraperitoneal group were 8.1% and 42.9%, respectively (p = 0.005). When evaluating only patients with CDC class 1 wounds, the recurrence rate in the retro-rectus group was 8.2% and the intraperitoneal group was 50% (p = 0.02). Overall, the average patient follow-up was 22 months and did not differ between groups. Both the retro-rectus and intraperitoneal groups indicated a significant (p < 0.05) improvement in quality of life from baseline. No long-term (> 7 days) antibiotics were used and no mesh implants were removed during the study. CONCLUSION:Patients who underwent open complex ventral hernia repairs with bio-absorbable mesh in the retro-rectus position experienced lower overall complication rates than those with intraperitoneal mesh placement. Despite a larger hernia defect in the retro-rectus group, recurrence rates were significantly reduced with retro-rectus placement of mesh compared to intraperitoneal placement. In addition, recurrence rates using bio-absorbable mesh in clean wounds are comparable to previously published recurrence rates with permanent mesh.
Entities:
Keywords:
Bio-absorbable mesh; Open complex ventral hernia repair; Retro-rectus placement
Authors: Rebeccah B Baucom; Jenny Ousley; Irene D Feurer; Gloria B Beveridge; Richard A Pierce; Michael D Holzman; Kenneth W Sharp; Benjamin K Poulose Journal: Am J Surg Date: 2015-07-31 Impact factor: 2.565
Authors: William S Cobb; Jeremy A Warren; Joseph A Ewing; Alex Burnikel; Miller Merchant; Alfredo M Carbonell Journal: J Am Coll Surg Date: 2015-01-28 Impact factor: 6.113
Authors: Kamal M F Itani; Michael Rosen; Daniel Vargo; Samir S Awad; George Denoto; Charles E Butler Journal: Surgery Date: 2012-07-03 Impact factor: 3.982
Authors: Alfredo M Carbonell; Cory N Criss; William S Cobb; Yuri W Novitsky; Michael J Rosen Journal: J Am Coll Surg Date: 2013-09-14 Impact factor: 6.113
Authors: Frederik Helgstrand; Jacob Rosenberg; Henrik Kehlet; Lars N Jorgensen; Thue Bisgaard Journal: J Am Coll Surg Date: 2012-12-07 Impact factor: 6.113
Authors: David M Krpata; Brian J Schmotzer; Susan Flocke; Judy Jin; Jeffrey A Blatnik; Bridget Ermlich; Yuri W Novitsky; Michael J Rosen Journal: J Am Coll Surg Date: 2012-08-04 Impact factor: 6.113
Authors: T S de Vries Reilingh; H van Goor; J A Charbon; C Rosman; E J Hesselink; G J van der Wilt; R P Bleichrodt Journal: World J Surg Date: 2007-04 Impact factor: 3.352
Authors: Jay F Yu; Hannah E Goldblatt; Katie Alter-Troilo; Emily Hetzel; Matthew I Goldblatt Journal: Surg Endosc Date: 2021-12-02 Impact factor: 3.453